#GATOS QUERATITIS OCULAR PDF#

diagnóstico de desordens da superfície ocular. RESUMO Propôs-se comparar as técnicas citológicas de abrasão conjuntival com escova e de impressão com transferência, em gatos, quanto à facilidade de colheita e confecção das lâminas, o resultado final na preservação da morfologia e evidenciação de estruturas celulares, a fim de disponibilizar ao clínico veterinário uma alternativa de baixo custo, fácil execução e interpretação no auxílio ao. Results with radiotherapy and cryotherapy for deep scleral invasion have been unpredictable or unacceptable compared with surgery. Surgical options include wide excision and partial sclerectomy with cryotherapy for superficial invasion and/or interferon therapy.

Behaviorally aggressive or rapidly recurrent epithelial squamous tumors with 'inflammatory' features or unusual clinical characteristics should be initially stained at multiple levels for the detection of parsimonious mucus secretion. Focal CK7 immunopositivity in any epibulbar squamous dysplasia or in invasive carcinoma should lead to suspicion of a mucoepidermoid carcinoma. Intraocular extension exhibited micro-and macrocysts with minimal goblet cells.

Biopsies of the epibulbar lesion were initially misinterpreted as a squamous cell carcinoma but on review harbored CK7-positive cells and contained rare goblet cells brought out with Alcian blue and mucicarmine staining. A 63-year-old woman with a history of rheumatoid arthritis and idiopathic sclerosing cholangitis developed scleral thinning, anterior chamber cells and flare, and uveal prolapse. More focused strategies should be developed for its earlier histopathologic diagnosis and improved management (historical recurrence rate of 85%).

239000002997 ophthalmic solution Substances 0.The current case of conjunctival mucoepidermoid carcinoma offers features that expand the biologic spectrum afforded by this tumor.

229940054534 Ophthalmic Solution Drugs 0.000 title claims abstract description 22.

229960001265 ciclosporin Drugs 0.000 title claims abstract description 59.

108010036949 Cyclosporine Proteins 0.000 title claims abstract description 61.

Application granted granted Critical Publication of ES2746701T3 publication Critical patent/ES2746701T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US201261614218P priority Critical Priority to FR1252583A priority patent/FR2988297B1/en Application filed by Laboratoires Thea SAS filed Critical Laboratoires Thea SAS Priority to PCT/FR2013/050557 priority patent/WO2013140071A1/en First worldwide family litigation filed litigation Critical (T3) 'Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Laboratoires Thea SAS Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Inventor Emmanuel Muriaux Fabrice Mercier Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES13715338T Other languages Spanish ( es)

#GATOS QUERATITIS OCULAR PDF#

Cyclosporin A-based aqueous ophthalmic solutionĭownload PDF Info Publication number ES2746701T3 ES2746701T3 ES13715338T ES13715338T ES2746701T3 ES 2746701 T3 ES2746701 T3 ES 2746701T3 ES 13715338 T ES13715338 T ES 13715338T ES 13715338 T ES13715338 T ES 13715338T ES 2746701 T3 ES2746701 T3 ES 2746701T3 Authority ES Spain Prior art keywords solution advantageously solution according cyclosporin polymer Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.

Gatos queratitis ocular